Patents by Inventor Gema Tarrason

Gema Tarrason has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING TIMOLOL AND THEIR USE IN THE TREATMENT OF ROSACEA BY TOPICAL ADMINISTRATION
    Publication number: 20210220368
    Abstract: The present invention relates to the use of timolol in treating rosacea, and to pharmaceutical compositions comprising timolol.
    Type: Application
    Filed: June 15, 2017
    Publication date: July 22, 2021
    Applicant: Almirall, S.A.
    Inventors: Bernat Vidal Juan, Maria Victoria Revilla Sanchez, Gema Tarrason Encuentra
  • COMPOSITIONS COMPRISING TIMOLOL AND AN ANTI-INFLAMMATORY AGENT
    Publication number: 20190231788
    Abstract: The present invention relates to combinations comprising timolol and a compound useful for the treatment of rosacea selected from ivermectin, metronidazole and praziquantel and to the use of these combinations in the topical treatment of rosacea.
    Type: Application
    Filed: June 15, 2017
    Publication date: August 1, 2019
    Applicant: Almirall, S.A.
    Inventors: Nuria Godessart Marina, Gema Tarrason Encuentra
  • 4-Amino-5-oxo-8-phenyl-5H-pyrido(2,3-D) pyrimidine derivatives as tyrosine kinase and raf kinase inhibitors for the treatment of tumours
    Patent number: 7745434
    Abstract: Compounds of the formula (I), in which R6, R7, R8, R9, Het1, X and X? have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours.
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: June 29, 2010
    Assignee: Merck Patent GmbH
    Inventors: Guenter Hoelzemann, Karl-August Ackermann, Helene Crassier, Alfred Jonczyk, Wilfried Rautenberg, Gema Tarrason, Elisabet Rosell-Vives, Jaume Adan, Claudia Cases
  • 4-Amino-5-Oxo-8-Phenyl-5H-Pyrido(2,3-D) Pyrimidine Derivatives as Tyrosine Kinase and Raf Kinase Inhibitors for the Treatment of Tumours
    Publication number: 20080146560
    Abstract: Compounds of the formula (I), in which R6, R7, R8, R9, Het1, X and X? have the meanings indicated in claim 1, are inhibitors of tyrosine kinases, in particular TIE-2, and Raf kinases and can be employed, inter alia, for the treatment of tumours
    Type: Application
    Filed: October 20, 2005
    Publication date: June 19, 2008
    Inventors: Guenter Hoelzemann, Karl-August Ackermann, Helene Grassier, Alfred Jonczyk, Wilfried Rautenberg, Gema Tarrason, Elisabet Rosell-Vives, Jaume Adan, Claudia Cases
  • Identification of n-alkylglycine trimers for induction of apoptosis
    Publication number: 20060229255
    Abstract: N-alkylglycine trimers with the capacity to arrest the cell cycle in human cancer cells and to induce apoptosis useful for the therapy of cancer. Combination of said N-alkylglycine trimers with taxol.
    Type: Application
    Filed: April 8, 2004
    Publication date: October 12, 2006
    Inventors: Gema Tarrason, Claudia Cases, Jaume Piulats, Angel Messeguer, Nuria Cortes, Isabel Masip